Vyne Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vyne therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vyne Therapeutics Today - Breaking & Trending Today

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Expands By 1,157.1%

VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 88,000 shares, a growth of 1,157.1% from the December 15th total of 7,000 shares. Based on an average trading volume of 401,800 shares, the short-interest ratio […] ....

Patrickg Lepore , Susquehanna International Group , Vyne Therapeutics Inc , Mackenzie Financial Corp , Beacon Pointe Advisors , Therapeutics Inc , Securities Exchange Commission , Cetera Advisor Networks , Get Free Report , Director Patrick , Exchange Commission , Financial Corp , Advisor Networks , Pointe Advisors , International Group , Trading Down , Vyne Therapeutics , Nasdaq Vyne ,

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Decreases By 94.4%

VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Free Report) saw a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 7,000 shares, a drop of 94.4% from the November 30th total of 124,800 shares. Based on an average daily volume of 366,400 shares, the days-to-cover ratio […] ....

Patrickg Lepore , Therapeutics Company Profile , Millennium Management , Securities Exchange Commission , Vyne Therapeutics Inc , Renaissance Technologies , Mackenzie Financial Corp , Beacon Pointe Advisors , Cetera Advisor Networks , Therapeutics Inc , Get Free Report , Director Patrick , Exchange Commission , Advisor Networks , Pointe Advisors , Vyne Therapeutics , Nasdaq Vyne ,

Head to Head Comparison: VYNE Therapeutics (NASDAQ:VYNE) vs. Rocket Pharmaceuticals (NASDAQ:RCKT)

VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) and Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares VYNE Therapeutics […] ....

United States , New Jersey , Investigacion Biomedica , Fundacion Jimenez Diaz , Medioambientalesy Tecnol , Investigaciones Energ , Menlo Therapeutics Inc , Fred Hutchinson Cancer Research Center , Regents Of The University California , Rocket Pharmaceuticals Inc , Regenxbio Inc , Therapeutics Inc , Rocket Pharmaceuticals , Get Free Report , Rocket Pharmaceutical , Menlo Therapeutics , Centro De Investigaciones Energ , Centro De Investigacion Biomedica En Red , Fundacion Instituto , Sanitaria Fundacion Jimenez Diaz , Vyne Therapeutics , Nasdaq Vyne , Stock Comparison , Stock Analysis ,

VYNE Therapeutics (NASDAQ:VYNE) Price Target Lowered to $5.75 at HC Wainwright

VYNE Therapeutics (NASDAQ:VYNE – Free Report) had its target price cut by HC Wainwright from $28.00 to $5.75 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for VYNE Therapeutics’ Q3 2023 earnings at ($0.76) EPS, Q4 2023 […] ....

Therapeutics Inc , Beacon Pointe Advisors , Susquehanna International Group , Renaissance Technologies , Mackenzie Financial Corp , Free Report , Get Free Report , International Group , Financial Corp , Vyne Therapeutics , Nasdaq Vyne , Lower Price Target , Hc Wainwright ,

VYNE Therapeutics Sees Positive Data for VYN201, VYN202

By Chris Wack VYNE Therapeutics said Monday that it saw positive data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with. ....

Chris Wack , Article Normal , Biotechnology Services , Healthcare Life Sciences , Biological Therapy , Healthcare Provision , Autoimmune Diseases , Political General News , Medical Conditions , Vyne Therapeutics , General News , Life Sciences ,